Pancreatic Cancer Research

ResearcherConsejo Nacional de Investigaciones Científicas y TécnicasActive in the last 2 years

Agustín Yaneff

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0503-5897; OpenAlex author ID A5088094413. Sources: OpenAlex.

Their work

Papers
7 (first author 1, last author 2)
Trials
0
Grants
0
Labs led
0
Collaborators
21
Papers, trials and grants by year

2019: 1 paper · 2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper · 2024: 2 papers · 2025: none · 2026: 2 papers

Papers 7

  1. Stage-resolved gene drivers of pancreatic ductal adenocarcinoma progression and therapeutic vulnerabilities. Co-author DOI 10.1016/j.isci.2026.115164↗
  2. Pathway-driven therapeutic stratification in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.tranon.2026.102920↗
  3. Flurbiprofen inhibits cAMP transport by MRP4/ABCC4 increasing the potency of gemcitabine treatment in PDAC cell models. Last author DOI 10.1016/j.ijbiomac.2024.136386↗
  4. The xenobiotic transporter ABCC4/MRP4 promotes epithelial mesenchymal transition in pancreatic cancer. Co-author DOI 10.3389/fphar.2024.1432851↗
  5. [The mRNA vaccine for the treatment of pancreatic cancer is here to stay]. Last author PMID 37582144↗
  6. Multidrug transporter MRP4/ABCC4 as a key determinant of pancreatic cancer aggressiveness. Co-author DOI 10.1038/s41598-020-71181-w↗
  7. Identification of MRP4/ABCC4 as a Target for Reducing the Proliferation of Pancreatic Ductal Adenocarcinoma Cells by Modulating the cAMP Efflux. First author DOI 10.1124/mol.118.115444↗

Closest collaborators

The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ana Sahores · 6 shared papers, 2019–2026 · strength 0.95
  2. Nicolas Alejandro Fraunhoffer · 4 shared papers, 2023–2026 · strength 0.76
  3. Juan Iovanna · 4 shared papers, 2023–2026 · strength 0.76
  4. Nelson Dusetti · 4 shared papers, 2023–2026 · strength 0.76
  5. Carlos Alberto Davio · 5 shared papers, 2019–2024 · strength 0.75
  6. Oscar Mazza · 3 shared papers, 2023–2026 · strength 0.57
  7. María Eugenia Pasqualini · 3 shared papers, 2023–2026 · strength 0.57
  8. María Noé Garcia · 3 shared papers, 2023–2026 · strength 0.57
  9. Eduardo Chuluyán · 3 shared papers, 2023–2026 · strength 0.57
  10. Daniela Laura Papademetrio · 3 shared papers, 2023–2026 · strength 0.57
  11. Daniel Grasso · 3 shared papers, 2023–2026 · strength 0.57
  12. Betina González · 3 shared papers, 2023–2024 · strength 0.56
  13. Jonathan Garnier · 2 shared papers, 2026 · strength 0.42
  14. Brice Chanez · 2 shared papers, 2026 · strength 0.42
  15. Ramiro Héctor Cerviño · 1 shared paper, 2024 · strength 0.23
  16. Analía Meilerman Abuelafia · 1 shared paper, 2026 · strength 0.21
  17. Pascal R. Hammel · 1 shared paper, 2026 · strength 0.21
  18. Samanta N. Gancedo · 1 shared paper, 2024 · strength 0.19
  19. Alejandro Carozzo · 2 shared papers, 2019–2020 · strength 0.19
  20. Patricia Santofimia‐Castaño · 1 shared paper, 2023 · strength 0.14
  21. Natalia Fernández · 1 shared paper, 2019 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.